Evidence map›Paper›PMID 42024262›Full record

ReviewCurrent cardiology reports2026

Imaging in Cardio-Oncology: Role of Novel Echo Parameters in Breast Cancer and Gynecologic Malignancies.

Sharon Andrade-Bucknor, Beatriz P Rivera Rodriguez, Carol Ma, Radmila Lyubarova, Lavanya Kondapalli

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sharon Andrade-BucknorDivision of Cardiology, University of Miami, Miami, FL, USA.
Beatriz P Rivera RodriguezDivision of Cardiology, University of Miami, Miami, FL, USA.
Carol MaAdventHealth Medical Group, Cardiology, Orlando, FL, USA.
Radmila LyubarovaDepartment of Medicine, Division of Cardiology, Albany Medical College, Albany, NY, USA.
Lavanya KondapalliDepartment of Medicine, Division of Cardiology, University of Colorado Anschutz Medical Campus, 12631 E. 17th Avenue, Mailstop B130, Aurora, CO, 80045, USA. lavanya.kondapalli@cuanschutz.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTo review the use of echocardiography in monitoring for cardiotoxicity in women with breast or gynecologic cancer. RECENT

findingsLeft ventricular ejection fraction (LVEF) is a mainstay of monitoring for cancer treatment related cardiotoxicity (CTRCD). Three-dimensional volumetric LVEF is recommended over other LVEF assessments like Simpson’s biplane. Studies have shown that changes in global longitudinal strain (GLS) may indicate subclinical cardiotoxicity. Diastolic function, right ventricular function, myocardial work, left atrial strain, and stress testing all have emerging roles in monitoring for cardiotoxicity. Finally, applications of artificial intelligence in monitoring for CTRCD are discussed. Echocardiography remains a powerful tool for early detection and monitoring of cardiotoxicity associated with cancer therapy. Several novel echocardiography parameters are being investigated and have the potential to further enhance early detection of cardiotoxicity.

Indexed as

Antineoplastic AgentsBreast NeoplasmsCardiotoxicityEchocardiographyGenital Neoplasms, FemaleEchocardiography, Three-DimensionalFemaleGlobal Longitudinal StrainHumansStroke VolumeAntineoplastic AgentsBreast cancerCardiotoxicityEchocardiographyGynecologic malignancy

Identifiers

PMID42024262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.